In accordance with information provided in connection with Surgical Science announcing the acquisition of Simbionix on July 28, 2021, a number of key individuals at Simbionix have acquired shares from Surgical Sciences' two largest owners. A total of 103,018 shares have been acquired by the key individuals from the two main owners and board members Jan Bengtsson (Marknadspotential AB - 58,360 shares) and Roland Bengtsson (Semelin Kapitalförvaltning AB - 44,658 shares), at a price of SEK 210.00 per share (corresponding to the subscription price in the directed new share issue carried out in connection with the acquisition).

Please refer to press releases dated July 28 2021 for further details.

Gothenburg, Sweden, August 31, 2021
Surgical Science Sweden AB (publ)

The press release is available in the attachment or via

https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Gisli Hennermark, CEO
Telephone: +46-70-420 83 00
E-mail: gisli.hennermark@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based laparoscopic and endoscopic training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the operating room. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science is headquartered in Gothenburg, Sweden and present in Stockholm, Sweden, Tel Aviv, Israel as well as in Seattle, Washington, in the US. Through sales offices in the US, France, China and UAE as well as a global network of distributors, Surgical Science maintains a presence in most markets around the world. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Telephone: 08-463 83 00; E-mail: certifiedadviser@penser.se).

Attachments

Transactions between the largest owners of Surgical Science and key individuals in Simbionix have been completed

© Modular Finance, source Nordic Press Releases